EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antineoplastic and Immunomodulatory Effects of Cabozantinib in Continuous and Primary Human Anaplastic Thyroid Cancer Cells

Giusy Elia iD, Silvia Martina Ferrari, Eugenia Balestri, Chiara Botrini, Francesca Ragusa, Valeria Mazzi, Licia Rugani iD, Simona Piaggi iD, Elena Catania Romizi, Oriana Fabrazzo, Eleonora Giorgetti, Alessia Baglini und 6 weitere

Cancers · 23.07.2026 · 18 (15) · 2379

DOI: 10.3390/cancers18152379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 23.07.2026. Verfasst von Giusy Elia und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, 56126 Pisa, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: To date, the antineoplastic effect of cabozantinib in in vitro anaplastic thyroid cancer (ATC) cells has not yet been investigated. We aim to evaluate the antineoplastic and immunomodulatory effect of cabozantinib in both primary and continuous ATC cell cultures in vitro.

Methods

The antineoplastic activity of cabozantinib was evaluated in ATC cell lines (8305C; CAL62) and in five different primary ATC cells obtained directly from patients.

Results

Increasing concentrations of cabozantinib were tested showing a significant decrease in viability/proliferation and an increase in apoptosis in the treated cells vs. control. A scratch assay was also performed to evaluate the effect of cabozantinib on migration showing a significant inhibition of it vs. control. Moreover, we showed a decrease in the secretion of both CXCL10 and CCL2 (T-helper (Th)1 and (Th)2 chemokines) under the treatment with cabozantinib, thus suggesting an immunomodulatory effect of the drug.

Conclusions

A personalized approach for each patient can be achieved by using primary human ATC cells obtained directly from the patient, since in vitro studies permit assessing the chemosensitivity of cells obtained from each subject. These results in our opinion are very promising for a future in vivo evaluation of cabozantinib in patients with ATC.

Schlagwörter

Stichwörter der Autor:innen

anaplastic thyroid cancercabozantinibin vitro studyprimary cell cultures

Autor:innen und Institutionen

  • Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, 56126 Pisa, Italy.
  • Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
  • Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, 80131 Naples, Italy.
  • World Allergy Organization (WAO) Center of Excellence, 80131 Naples, Italy.
  • Institute of Experimental Endocrinology and Oncology (IEOS), National Research Council, 80131 Naples, Italy.
  • Department of Medico-Surgical Sciences and Biotechnologies, Endocrinology Section, "Sapienza" University of Rome, 04100 Latina, Italy.

ORCID-Profile: Giusy Elia, Licia Rugani, Simona Piaggi, Salvatore Ulisse, Gabriele Materazzi, Alessandro Antonelli

Zitieren

APA

Elia, G., Ferrari, S. M., Balestri, E., Botrini, C., Ragusa, F., Mazzi, V., Rugani, L., Piaggi, S., Catania Romizi, E., Fabrazzo, O., Giorgetti, E., Baglini, A., Varricchi, G., Virili, C., Ulisse, S., Materazzi, G., Antonelli, A., & Fallahi, P. (2026). Antineoplastic and Immunomodulatory Effects of Cabozantinib in Continuous and Primary Human Anaplastic Thyroid Cancer Cells. Cancers, 18(15), 2379. https://doi.org/10.3390/cancers18152379

Vancouver

Elia G, Ferrari SM, Balestri E, Botrini C, Ragusa F, Mazzi V, et al. Antineoplastic and Immunomodulatory Effects of Cabozantinib in Continuous and Primary Human Anaplastic Thyroid Cancer Cells. Cancers. 2026;18(15):2379. doi:10.3390/cancers18152379

BibTeX
@article{Elia2026,
  author = {Elia, Giusy and Ferrari, Silvia Martina and Balestri, Eugenia and Botrini, Chiara and Ragusa, Francesca and Mazzi, Valeria and Rugani, Licia and Piaggi, Simona and Catania Romizi, Elena and Fabrazzo, Oriana and Giorgetti, Eleonora and Baglini, Alessia and Varricchi, Gilda and Virili, Camilla and Ulisse, Salvatore and Materazzi, Gabriele and Antonelli, Alessandro and Fallahi, Poupak},
  title = {Antineoplastic and Immunomodulatory Effects of Cabozantinib in Continuous and Primary Human Anaplastic Thyroid Cancer Cells},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {15},
  pages = {2379},
  doi = {10.3390/cancers18152379}
}
Kostenlos starten →